Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.

Detering R, Karthaus EG, Borstlap WAA, Marijnen CAM, van de Velde CJH, Bemelman WA, Beets GL, Tanis PJ, Aalbers AGJ; Dutch Snapshot Research Group.

Eur J Surg Oncol. 2019 Jun 17. pii: S0748-7983(19)30510-4. doi: 10.1016/j.ejso.2019.06.016. [Epub ahead of print]

PMID:
31230980
2.

Robust contour propagation using deep learning and image registration for online adaptive proton therapy of prostate cancer.

Elmahdy MS, Jagt T, Zinkstok RT, Qiao Y, Shahzad R, Sokooti H, Yousefi S, Incrocci L, Marijnen CAM, Hoogeman M, Staring M.

Med Phys. 2019 May 21. doi: 10.1002/mp.13620. [Epub ahead of print]

PMID:
31111962
3.

Health-related quality of life of breast cancer patients after accelerated partial breast irradiation using intraoperative or external beam radiotherapy technique.

Jacobs DHM, Horeweg N, Straver M, Roeloffzen EMA, Speijer G, Merkus J, van der Sijp J, Mast ME, Fisscher U, Petoukhova AL, Zwanenburg AG, Marijnen CAM, Koper PCM.

Breast. 2019 Aug;46:32-39. doi: 10.1016/j.breast.2019.04.006. Epub 2019 Apr 28.

PMID:
31075670
4.

The effect of time interval from chemoradiation to surgery on postoperative complications in patients with rectal cancer.

Couwenberg AM, Intven MPW, Hoendervangers S, van der Sluis FJ, van Westreenen HL, Marijnen CAM, van Grevenstein WMU, Verkooijen HM; Dutch ColoRectal Audit.

Eur J Surg Oncol. 2019 Apr 25. pii: S0748-7983(19)30408-1. doi: 10.1016/j.ejso.2019.04.016. [Epub ahead of print]

PMID:
31053479
5.

Letter to the editor regarding "A systematic review comparing radiation toxicity after various endorectal techniques".

Rijkmans EC, Nout RA, Marijnen CAM.

Brachytherapy. 2019 Jul - Aug;18(4):564. doi: 10.1016/j.brachy.2019.02.006. Epub 2019 Apr 9. No abstract available.

PMID:
30979630
6.

Patient explicit consideration of tradeoffs in decision making about rectal cancer treatment: benefits for decision process and quality of life.

Pieterse AH, Kunneman M, van den Hout WB, Baas-Thijssen M, Geijsen ED, Ceha HM, Muller KM, van der Linden YM, Marijnen CAM, Stiggelbout AM.

Acta Oncol. 2019 Jul;58(7):1069-1076. doi: 10.1080/0284186X.2019.1594363. Epub 2019 Apr 11.

PMID:
30971150
7.

Predictive factors for response and toxicity after brachytherapy for rectal cancer; results from the HERBERT study.

Rijkmans EC, Marijnen CAM, van Triest B, Ketelaars M, Cats A, Inderson A, van den Ende RPJ, Laman MS, Kerkhof EM, Nout RA.

Radiother Oncol. 2019 Apr;133:176-182. doi: 10.1016/j.radonc.2019.01.034. Epub 2019 Feb 18.

PMID:
30935576
8.

MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.

van den Ende RPJ, Rigter LS, Kerkhof EM, van Persijn van Meerten EL, Rijkmans EC, Lambregts DMJ, van Triest B, van Leerdam ME, Staring M, Marijnen CAM, van der Heide UA.

Radiother Oncol. 2019 Mar;132:93-99. doi: 10.1016/j.radonc.2018.11.016. Epub 2018 Dec 21.

9.

Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.

Detering R, Borstlap WAA, Broeders L, Hermus L, Marijnen CAM, Beets-Tan RGH, Bemelman WA, van Westreenen HL, Tanis PJ; Dutch Snapshot Research Group.

Ann Surg Oncol. 2019 Feb;26(2):437-448. doi: 10.1245/s10434-018-07097-7. Epub 2018 Dec 13.

10.

Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal Cancer: The CARTS Study.

Stijns RCH, de Graaf EJR, Punt CJA, Nagtegaal ID, Nuyttens JJME, van Meerten E, Tanis PJ, de Hingh IHJT, van der Schelling GP, Acherman Y, Leijtens JWA, Bremers AJA, Beets GL, Hoff C, Verhoef C, Marijnen CAM, de Wilt JHW; CARTS Study Group.

JAMA Surg. 2019 Jan 1;154(1):47-54. doi: 10.1001/jamasurg.2018.3752.

PMID:
30304338
11.

Effectiveness and toxicity of conventional radiotherapy treatment for painful spinal metastases: a detailed course of side effects after opposing fields versus a single posterior field technique.

Westhoff PG, de Graeff A, Monninkhof EM, de Pree I, van Vulpen M, Leer JWH, Marijnen CAM, van der Linden YM; Dutch Bone Metastasis Study Group.

J Radiat Oncol. 2018;7(1):17-26. doi: 10.1007/s13566-017-0328-1. Epub 2017 Sep 19.

12.

Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients.

Jacobs DHM, Speijer G, Petoukhova AL, Roeloffzen EMA, Straver M, Marinelli A, Fisscher U, Zwanenburg AG, Merkus J, Marijnen CAM, Mast ME, Koper PCM.

Breast Cancer Res Treat. 2018 Jun;169(3):549-559. doi: 10.1007/s10549-018-4712-3. Epub 2018 Feb 19.

13.

Evaluation of clinical and endoscopic toxicity after external beam radiotherapy and endorectal brachytherapy in elderly patients with rectal cancer treated in the HERBERT study.

Rijkmans EC, van Triest B, Nout RA, Kerkhof EM, Buijsen J, Rozema T, Franssen JH, Velema LA, Laman MS, Cats A, Marijnen CAM.

Radiother Oncol. 2018 Mar;126(3):417-423. doi: 10.1016/j.radonc.2017.12.023. Epub 2018 Feb 3.

PMID:
29398154
14.

Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study.

Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, Bhangu A, Garm Spindler KL, Gray R, Handley K, Kaur M, Kerkhof E, Kronborg CJ, Magill L, Marijnen CAM, Nagtegaal ID, Nyvang L, Peters FP, Pfeiffer P, Punt C, Quirke P, Sebag-Montefiore D, Teo M, West N, de Wilt JHW; for STAR-TREC Collaborative Group.

BMJ Open. 2017 Dec 28;7(12):e019474. doi: 10.1136/bmjopen-2017-019474.

15.

Benefit of adaptive CT-based treatment planning in high-dose-rate endorectal brachytherapy for rectal cancer.

van den Ende RPJ, Rijkmans EC, Kerkhof EM, Nout RA, Ketelaars M, Laman MS, Marijnen CAM, van der Heide UA.

Brachytherapy. 2018 Jan - Feb;17(1):78-85. doi: 10.1016/j.brachy.2017.08.011. Epub 2017 Sep 28.

16.

Screening for psychological distress before radiotherapy for painful bone metastases may be useful to identify patients with high levels of distress.

Westhoff PG, de Graeff A, Monninkhof EM, Berveling MJ, van Vulpen M, Leer JWH, Marijnen CAM, Reyners AKL, van der Linden YM; Dutch Bone Metastasis Study Group.

Acta Oncol. 2017 Dec;56(12):1720-1727. doi: 10.1080/0284186X.2017.1374557. Epub 2017 Sep 12.

PMID:
28893119
17.

Reply to M. Wissing et al.

Wiltink LM, Nout RA, Fiocco M, Creutzberg CL, Marijnen CAM.

J Clin Oncol. 2017 Jun 1;35(16):1862. doi: 10.1200/JCO.2017.72.6125. Epub 2017 Mar 13. No abstract available.

PMID:
28549229
18.

Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.

van Ruler MA, Peters FP, Slingerland M, Fiocco M, Grootenboers DA, Vulink AJ, Marijnen CA, Neelis KJ.

Dis Esophagus. 2017 Apr 1;30(4):1-9. doi: 10.1093/dote/dow033.

PMID:
28375477
19.

Endorectal Brachytherapy Boost After External Beam Radiation Therapy in Elderly or Medically Inoperable Patients With Rectal Cancer: Primary Outcomes of the Phase 1 HERBERT Study.

Rijkmans EC, Cats A, Nout RA, van den Bongard DHJG, Ketelaars M, Buijsen J, Rozema T, Franssen JH, Velema LA, van Triest B, Marijnen CAM.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):908-917. doi: 10.1016/j.ijrobp.2017.01.033. Epub 2017 Jan 20.

PMID:
28366579
20.

Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.

Gietelink L, Wouters MWJM, Marijnen CAM, van Groningen J, van Leersum N, Beets-Tan RGH, Tollenaar RAEM, Tanis PJ; Dutch Surgical Colorectal Cancer Audit Group.

Eur J Surg Oncol. 2017 Jul;43(7):1297-1303. doi: 10.1016/j.ejso.2016.12.019. Epub 2017 Mar 10.

PMID:
28351504
21.

Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease.

Bosch SL, van Rooijen SJ, Bökkerink GM, Braam HJ, Derikx LA, Poortmans P, Marijnen CA, Nagtegaal ID, de Wilt JH.

Radiother Oncol. 2017 Apr;123(1):147-153. doi: 10.1016/j.radonc.2017.02.009. Epub 2017 Mar 10.

PMID:
28291546
22.

Oncologist, patient, and companion questions during pretreatment consultations about adjuvant cancer treatment: a shared decision-making perspective.

Pieterse AH, Kunneman M, Engelhardt EG, Brouwer NJ, Kroep JR, Marijnen CAM, Stiggelbout AM, Smets EMA.

Psychooncology. 2017 Jul;26(7):943-950. doi: 10.1002/pon.4241. Epub 2016 Sep 15.

PMID:
27502561
23.

A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.

Borstlap WA, Tanis PJ, Koedam TW, Marijnen CA, Cunningham C, Dekker E, van Leerdam ME, Meijer G, van Grieken N, Nagtegaal ID, Punt CJ, Dijkgraaf MG, De Wilt JH, Beets G, de Graaf EJ, van Geloven AA, Gerhards MF, van Westreenen HL, van de Ven AW, van Duijvendijk P, de Hingh IH, Leijtens JW, Sietses C, Spillenaar-Bilgen EJ, Vuylsteke RJ, Hoff C, Burger JW, van Grevenstein WM, Pronk A, Bosker RJ, Prins H, Smits AB, Bruin S, Zimmerman DD, Stassen LP, Dunker MS, Westerterp M, Coene PP, Stoot J, Bemelman WA, Tuynman JB.

BMC Cancer. 2016 Jul 21;16:513. doi: 10.1186/s12885-016-2557-x.

24.

Course of Quality of Life After Radiation Therapy for Painful Bone Metastases: A Detailed Analysis From the Dutch Bone Metastasis Study.

Westhoff PG, Verdam MGE, Oort FJ, Jobsen JJ, van Vulpen M, Leer JWH, Marijnen CAM, de Graeff A, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1391-1398. doi: 10.1016/j.ijrobp.2016.03.032. Epub 2016 Mar 29.

PMID:
27315664
25.

Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.

Borstlap WA, Coeymans TJ, Tanis PJ, Marijnen CA, Cunningham C, Bemelman WA, Tuynman JB.

Br J Surg. 2016 Aug;103(9):1105-16. doi: 10.1002/bjs.10163. Epub 2016 Jun 15. Review.

PMID:
27302385
26.

Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.

Bosch SL, Vermeer TA, West NP, Swellengrebel HA, Marijnen CA, Cats A, Verhoef C, van Lijnschoten I, de Wilt JH, Rutten HJ, Nagtegaal ID.

Histopathology. 2016 Nov;69(5):839-848. doi: 10.1111/his.13008. Epub 2016 Jul 26.

27.

The beneficial local and abscopal effect of splenic irradiation in frail patients with chronic lymphocytic leukaemia.

Aalbers AM, Aarts MJ, Krol AD, Marijnen CA, Posthuma EF.

Neth J Med. 2016 Mar;74(3):122-9.

28.

Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.

Wiltink LM, Nout RA, van der Voort van Zyp JR, Ceha HM, Fiocco M, Meershoek-Klein Kranenbarg E, Marinelli AW, van de Velde CJ, Marijnen CA.

Clin Colorectal Cancer. 2016 Sep;15(3):e93-9. doi: 10.1016/j.clcc.2016.02.012. Epub 2016 Feb 13.

29.

Predictive Value of Six Prognostic Scoring Systems for Spinal Bone Metastases: An Analysis Based on 1379 Patients.

Bollen L, Wibmer C, Van der Linden YM, Pondaag W, Fiocco M, Peul WC, Marijnen CA, Nelissen RG, Leithner A, Dijkstra SP.

Spine (Phila Pa 1976). 2016 Feb;41(3):E155-62. doi: 10.1097/BRS.0000000000001192.

PMID:
26866742
30.

The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version.

Stiggelbout AM, Kunneman M, Baas-Thijssen MC, Neijenhuis PA, Loor AK, Jägers S, Vree R, Marijnen CA, Pieterse AH.

Qual Life Res. 2016 Jul;25(7):1853-8. doi: 10.1007/s11136-015-1210-5. Epub 2015 Dec 28.

31.

The Quest for Evidence for Proton Therapy: Model-Based Approach and Precision Medicine.

Widder J, van der Schaaf A, Lambin P, Marijnen CA, Pignol JP, Rasch CR, Slotman BJ, Verheij M, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):30-6. doi: 10.1016/j.ijrobp.2015.10.004. Epub 2015 Oct 9.

PMID:
26684410
32.

A comprehensive longitudinal overview of health-related quality of life and symptoms after treatment for rectal cancer in the TME trial.

Wiltink LM, Marijnen CA, Meershoek-Klein Kranenbarg E, van de Velde CJ, Nout RA.

Acta Oncol. 2016;55(4):502-8. doi: 10.3109/0284186X.2015.1088171. Epub 2015 Sep 25.

PMID:
26406287
33.

Considering patient values and treatment preferences enhances patient involvement in rectal cancer treatment decision making.

Kunneman M, Marijnen CA, Baas-Thijssen MC, van der Linden YM, Rozema T, Muller K, Geijsen ED, Stiggelbout AM, Pieterse AH.

Radiother Oncol. 2015 Nov;117(2):338-42. doi: 10.1016/j.radonc.2015.09.005. Epub 2015 Sep 11.

PMID:
26372343
34.

Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Pomp J, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):694-701. doi: 10.1016/j.ijrobp.2015.06.024. Epub 2015 Jun 20.

PMID:
26281825
35.

[Decision-making in preoperative radiotherapy in rectal cancer: variation in provision of information].

Kunneman M, Marijnen CA, Rozema T, Ceha H, Grootenboers DA, Neelis KJ, Stiggelbout AM, Pieterse AH.

Ned Tijdschr Geneeskd. 2015;159:A9093. Dutch.

PMID:
26271170
36.

Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making.

Kunneman M, Engelhardt EG, Ten Hove FL, Marijnen CA, Portielje JE, Smets EM, de Haes HJ, Stiggelbout AM, Pieterse AH.

Acta Oncol. 2016;55(2):134-9. doi: 10.3109/0284186X.2015.1068447. Epub 2015 Aug 3.

PMID:
26237738
37.

Acute toxicity after a diverting stoma and spacer prior to chemoradiation in locally advanced rectal cancer.

van der Voort van Zyp JR, Ceha HM, Niehe V, Marinelli AW, Putter H, Marijnen CA.

Radiother Oncol. 2015 Jul;116(1):107-11. doi: 10.1016/j.radonc.2015.06.001. Epub 2015 Jul 14.

PMID:
26187017
38.

Probabilities of benefit and harms of preoperative radiotherapy for rectal cancer: What do radiation oncologists tell and what do patients understand?

Kunneman M, Stiggelbout AM, Marijnen CA, Pieterse AH.

Patient Educ Couns. 2015 Sep;98(9):1092-8. doi: 10.1016/j.pec.2015.05.009. Epub 2015 May 24.

PMID:
26025810
39.

Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).

Verseveld M, de Graaf EJ, Verhoef C, van Meerten E, Punt CJ, de Hingh IH, Nagtegaal ID, Nuyttens JJ, Marijnen CA, de Wilt JH; CARTS Study Group.

Br J Surg. 2015 Jun;102(7):853-60. doi: 10.1002/bjs.9809. Epub 2015 Apr 2.

PMID:
25847025
40.

Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial.

Chen TY, Wiltink LM, Nout RA, Meershoek-Klein Kranenbarg E, Laurberg S, Marijnen CA, van de Velde CJ.

Clin Colorectal Cancer. 2015 Jun;14(2):106-14. doi: 10.1016/j.clcc.2014.12.007. Epub 2014 Dec 31.

41.

Organ preservation in rectal cancer: have all questions been answered?

Marijnen CA.

Lancet Oncol. 2015 Jan;16(1):e13-22. doi: 10.1016/S1470-2045(14)70398-5. Epub 2014 Dec 29. Review.

PMID:
25638548
42.

Highlights from the seventh European Multidisciplinary Colorectal Cancer Congress (EMCCC) 2014.

Punt CJ, Nagtegaal ID, van de Velde CJ, Beets-Tan R, Cats A, Hoogerbrugge N, Marijnen CA.

Ecancermedicalscience. 2015 Jan 6;9:497. doi: 10.3332/ecancer.2015.497. eCollection 2015.

43.

Modern Treatment of Rectal Cancer Closes the Gap Between Common Adenocarcinoma and Mucinous Carcinoma.

Hugen N, van de Velde CJ, Bosch SL, Fütterer JJ, Elferink MA, Marijnen CA, Rutten HJ, de Wilt JH, Nagtegaal ID.

Ann Surg Oncol. 2015 Aug;22(8):2669-76. doi: 10.1245/s10434-014-4339-5. Epub 2015 Jan 7.

PMID:
25564178
44.

No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials.

Wiltink LM, Nout RA, Fiocco M, Meershoek-Klein Kranenbarg E, Jürgenliemk-Schulz IM, Jobsen JJ, Nagtegaal ID, Rutten HJ, van de Velde CJ, Creutzberg CL, Marijnen CA.

J Clin Oncol. 2015 May 20;33(15):1640-6. doi: 10.1200/JCO.2014.58.6693. Epub 2014 Dec 22.

PMID:
25534376
45.

Which benefits and harms of preoperative radiotherapy should be addressed? A Delphi consensus study among rectal cancer patients and radiation oncologists.

Kunneman M, Pieterse AH, Stiggelbout AM, Marijnen CA.

Radiother Oncol. 2015 Feb;114(2):212-7. doi: 10.1016/j.radonc.2014.11.034. Epub 2014 Dec 11.

46.

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.

Breugom AJ, van Gijn W, Muller EW, Berglund Å, van den Broek CB, Fokstuen T, Gelderblom H, Kapiteijn E, Leer JW, Marijnen CA, Martijn H, Meershoek-Klein Kranenbarg E, Nagtegaal ID, Påhlman L, Punt CJ, Putter H, Roodvoets AG, Rutten HJ, Steup WH, Glimelius B, van de Velde CJ; Cooperative Investigators of Dutch Colorectal Cancer Group and Nordic Gastrointestinal Tumour Adjuvant Therapy Group.

Ann Oncol. 2015 Apr;26(4):696-701. doi: 10.1093/annonc/mdu560. Epub 2014 Dec 5.

PMID:
25480874
47.

Feasibility of tailored follow-up for patients with early breast cancer.

van Hezewijk M, Smit DJ, Bastiaannet E, Scholten AN, Ranke GM, Kroep JR, Marijnen CA, van de Velde CJ.

Breast. 2014 Dec;23(6):852-8. doi: 10.1016/j.breast.2014.09.002. Epub 2014 Oct 28.

PMID:
25438712
48.

Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed.

Kunneman M, Marijnen CA, Rozema T, Ceha HM, Grootenboers DA, Neelis KJ, Stiggelbout AM, Pieterse AH.

Br J Cancer. 2015 Jan 6;112(1):39-43. doi: 10.1038/bjc.2014.546. Epub 2014 Oct 21.

49.

An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases.

Westhoff PG, de Graeff A, Monninkhof EM, Bollen L, Dijkstra SP, van der Steen-Banasik EM, van Vulpen M, Leer JW, Marijnen CA, van der Linden YM; Dutch Bone Metastasis Study Group.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):739-47. doi: 10.1016/j.ijrobp.2014.07.051. Epub 2014 Sep 24.

PMID:
25260489
50.

Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial.

Wiltink LM, Chen TY, Nout RA, Kranenbarg EM, Fiocco M, Laurberg S, van de Velde CJ, Marijnen CA.

Eur J Cancer. 2014 Sep;50(14):2390-8. doi: 10.1016/j.ejca.2014.06.020. Epub 2014 Jul 21.

Supplemental Content

Loading ...
Support Center